Clinical Trial Update: Incretin-based Drugs and Pancreatic Cancer

View source ↗

Summary

A completed observational study assessing whether incretin-based therapies for type 2 diabetes are linked to pancreatic cancer, highlighting potential safety co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Type 2 Diabetes Mellitus

Drugs mentioned

• Incretin-based diabetes therapies (GLP-1 receptor agonists and DPP-4 inhibitors)

Snippet

Sponsor: Canadian Network for Observational Drug Effect Studies, CNODES | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED